Evidence map›Paper›PMID 36132724›Full record

ArticleNanoscale advances2019

Using evolved gas analysis - mass spectrometry to characterize adsorption on a nanoparticle surface.

Jordi Martínez-Esaín, Teresa Puig, Xavier Obradors, Josep Ros, Jordi Farjas, Pere Roura-Grabulosa, Jordi Faraudo, Ramón Yáñez, Susagna Ricart

Abstract read
In one paragraph

Article in Nanoscale advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jordi Martínez-EsaínDepartament de Química, Universitat Autònoma de Barcelona 08193 Bellaterra Spain.ORCID https://orcid.org/0000-0002-8420-8559
Teresa PuigInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) 08193 Bellaterra Spain ricart@icmab.es.ORCID https://orcid.org/0000-0002-1873-0488
Xavier ObradorsInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) 08193 Bellaterra Spain ricart@icmab.es.ORCID https://orcid.org/0000-0003-4592-7718
Josep RosDepartament de Química, Universitat Autònoma de Barcelona 08193 Bellaterra Spain.ORCID https://orcid.org/0000-0002-2391-2403
Jordi FarjasUniversity of Girona Campus Montilivi, Edif. PII E17071 Girona Spain.ORCID https://orcid.org/0000-0002-4093-9843
Pere Roura-GrabulosaUniversity of Girona Campus Montilivi, Edif. PII E17071 Girona Spain.ORCID https://orcid.org/0000-0003-4964-1362
Jordi FaraudoInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) 08193 Bellaterra Spain ricart@icmab.es.ORCID https://orcid.org/0000-0002-6315-4993
Ramón YáñezDepartament de Química, Universitat Autònoma de Barcelona 08193 Bellaterra Spain.
Susagna RicartInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) 08193 Bellaterra Spain ricart@icmab.es.ORCID https://orcid.org/0000-0003-4196-2081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The surface chemistry of nanoparticles is the key factor to control and predict their interactions with molecules, ions, other particles, other materials, or substrates, determining key properties such as nanoparticle stability or biocompatibility. In consequence, the development of new techniques or modification of classical techniques to characterize nanoparticle surfaces is of utmost importance. Here, a classical analysis technique, thermally evolved gas analysis - mass spectrometry (EGA-MS), is employed to obtain an image of the nanoparticle-solvent interface, unraveling the molecules present on the surface. As the use of complementary techniques is urged, the validity of EGA-MS characterization is corroborated by comparison with a previously reported surface characterization method. Previous studies were based on several experimental techniques and MD simulations using YF

Identifiers

PMID36132724
PMCPMC9417425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.